Drug Approval | October 19, 2022
USFDA visit to Alembic Pharmaceuticals Panelav facility
None of the observations are related to data integrity and Alembic Pharmaceuticals management believes that they are addressable
None of the observations are related to data integrity and Alembic Pharmaceuticals management believes that they are addressable
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
Roflumilast Tablets had annual sales of US $248 million in the United States according to IQVIA data
Valbenazine Capsules had annual sales of US $781 million in the United States according to IQVIA data
Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures
The move will add new global talent to Cytel’s Strategic Consulting group
ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
68% of children on a higher dose of Dupixent achieved histological disease remission at week 16
This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer.
Subscribe To Our Newsletter & Stay Updated
